Search
for
Sort by
Research 61–90 of 1000+
- Recent advances in understanding of radiation-induced skin tissue reactions with respect to acute tissue injury and late adverse effect
- Non‐ablative Er:YAG laser is an effective tool in the treatment arsenal of androgenetic alopecia
- Use of genetics in the prediction of success in male pattern hair loss therapy and mechanistic studies
- Convergent Regenerative Strategies in PM&R for Musculoskeletal and Hair Restoration: Integration of PRP, Exosomes, and Physical Modalities
- Phytochemicals as Modulators of Human Endocrine Function: Bridging Traditional Remedies and Hormonal Health
- Risk assessment of the top 60 drugs for drug-related sexual dysfunction: a disproportion analysis from the Food and Drug Administration adverse event reporting system
- Suicidality Risks Associated with Finasteride, a 5-Alpha Reductase Inhibitor: An Evaluation of Real-World Data from the FDA Adverse Event Reports
- COVID‐19, androgens, and androgenic alopecia
- Platelet-rich plasma-derived exosomes stimulate hair follicle growth through activation of the Wnt/β-Catenin signaling pathway
- The JAK/STAT signaling pathway: from bench to clinic
- Targeted protein degradation of Wnt/β-catenin signaling pathway: an effective strategy for cancer therapy
- 5α-Reductase Isoenzymes: From Neurosteroid Biosynthesis to Neuropsychiatric Outcomes
- Dupilumab for prurigo nodularis: real-world outcomes up to 104 weeks from the Dupilumab Italian Prurigo Nodularis (DUPItaPN) study
- Treatment of Androgenetic Alopecia Using PRP to Target Dysregulated Mechanisms and Pathways
- Intradiscal platelet-rich plasma for discogenic low back pain: a prospective cohort study of early clinical outcomes and quantitative MRI findings
- Safety and Efficacy of Mesotherapy with Placenta Polypeptide Injection for Moderate-to-Severe Sensitive Skin: A Multicenter, Randomized, Controlled Trial
- Topical Tacrolimus, Clobetasol, and Minoxidil (TCM) for Primary Cicatricial Alopecias: A Retrospective Analysis of Clinical Outcomes and Safety
- Case Report: Successful treatment of pediatric alopecia universalis with ritlecitinib after failure of baricitinib
- A 52-Week Real-Life Study of Baricitinib in Moderate to Severe Alopecia Areata: Clinical, Trichoscopic Assessment and Patient Reported Outcomes
- Cytokine-Targeting Biologic Therapies for Alopecia Areata: A Comprehensive Review of Mechanism of Action, Clinical Efficacy, and Adverse Events
- Toxic Side Effects of Targeted Therapies and Immunotherapies Affecting the Skin, Oral Mucosa, Hair, and Nails
- Anabolic androgenic steroids and carcinogenicity focusing on Leydig cell: a literature review
- Microneedling and Its Use in Hair Loss Disorders: A Systematic Review
- Implementing patient safety and quality improvement in dermatology. Part 1: Patient safety science
- Role of β-Catenin Activation Levels and Fluctuations in Controlling Cell Fate
- From mechanisms to therapies: current advances breakthroughs in alopecia areata immunopathology
- Post-marketing safety signals of four JAK inhibitors for alopecia areata: an indication-restricted FAERS pharmacovigilance study
- Modern Therapies for Discoid Lupus Erythematosus: A Narrative Review
- Vitiligo—Current Treatment Options and Future Perspectives
- Cannabis sativa